Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.
Eli Lilly has unveiled plans to invest $27 billion in the construction of four new manufacturing plants in the United States. Getty Images The new sites will be announced later this year and are ...
Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 25 trades. If we consider the specifics of ...
Business Insider on MSN25d
New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.Eli Lilly's weight-loss drugs include Mounjaro and Zepbound.Sandy Huffaker for The Washington Post/Getty Images Weight-loss drugs such as Ozempic and Zepbound cost $900 to $1,500 for a month's supply.
After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback